Novartis revenue decreased from $51.9 billion in 2018 to $47.4 billion in 2019, a (8.6%) decrease.

Annual Revenue ($)

Novartis revenue was $47.45 b in FY, 2019 which is a (8.6%) year over year decrease from the previous period.

Quarterly Revenue ($)

FY, 2017FY, 2018FY, 2019
Revenue$49.11 b$51.9 b$47.45 b
Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020
Revenue$12.69 b$13.16 b$12.78 b$11.11 b$11.76 b$12.17 b$12.28 b$11.35 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Novartis revenue breakdown by business segment: 20.5% from Sandoz and 79.5% from Innovative Medicines

Novartis revenue breakdown by geographic segment: 5.6% from Japan , 34.3% from United States, 5.1% from France, 8.7% from Germany and 46.3% from Other

FY, 2018FY, 2019FY, 2017
Innovative Medicines$35.63 b$37.71 b$33.03 b
Sandoz$10.04 b$9.73 b$10.06 b
Alcon$7.15 b$6.02 b
FY, 2018FY, 2019FY, 2017
United States$17.56 b$16.28 b$16.94 b
Germany$4.18 b$4.12 b$3.69 b
United Kingdom$1.26 b$1.16 b
France$2.71 b$2.44 b$2.49 b
Other$22.17 b$21.1 b$20.82 b
Switzerland $852 m$848 m$836 m
Japan $3.17 b$2.66 b$3.18 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu